ClinicalTrials.Veeva

Menu

Standard Follow-up Program (SFP) for Breast Cancer Patients (SFPMAMMA)

U

University Medical Center Groningen (UMCG)

Status

Invitation-only

Conditions

Breast Cancer

Treatments

Radiation: Radiotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT06429995
SFP MAMMA

Details and patient eligibility

About

Motive:

In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from breast cancer patients.

Goal:to set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.

A standard database of patiënts receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.

A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

Enrollment

10,000 estimated patients

Sex

Female

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with breast cancer Patients receiving a radiotherapy dose

Exclusion criteria

  • Failure to comply with any of the inclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems